Cite
APA Citation
Komaki, Y., Kanmura, S., Yutsudo, K., Kuwazuru, K., Komaki, F., Tanaka, A., Nishimata, N., Sameshima, Y., Sasaki, F., Ohi, H., Nakamura, Y., Tokushige, K., Sameshima, Y., & Ido, A. (2021). infliximab therapy intensification based on endoscopic activity is related to suppress treatment discontinuation in patients with Crohn disease. Medicine, 100(6), . http://access.bl.uk/ark:/81055/vdc_100123151641.0x00002f